Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
25.7M
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
22.7M
-
Shares change
-
+1.44M
-
Total reported value, excl. options
-
$265M
-
Value change
-
+$16.7M
-
Number of buys
-
37
-
Number of sells
-
-16
-
Price
-
$11.70
Significant Holders of Benitec Biopharma Inc. - Common Stock (BNTC) as of Q2 2025
61 filings reported holding BNTC - Benitec Biopharma Inc. - Common Stock as of Q2 2025.
Benitec Biopharma Inc. - Common Stock (BNTC) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.7M shares
of 25.7M outstanding shares and own 88.31% of the company stock.
Largest 10 shareholders include SUVRETTA CAPITAL MANAGEMENT, LLC (9.88M shares), JANUS HENDERSON GROUP PLC (2.9M shares), FRANKLIN RESOURCES INC (2.7M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.97M shares), VANGUARD GROUP INC (969K shares), Nantahala Capital Management, LLC (838K shares), BlackRock, Inc. (719K shares), INFINITUM ASSET MANAGEMENT, LLC (500K shares), GEODE CAPITAL MANAGEMENT, LLC (415K shares), and Schonfeld Strategic Advisors LLC (260K shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.